Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models

por Nakashima, Hideyuki, Fujisawa, Toshio, Husain, Syed R, Puri, Raj K
Publicado 2010

Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma

por Han, Jing, Fujisawa, Toshio, Husain, Syed R, Puri, Raj K
Publicado 2014

Gene therapy for cancer: regulatory considerations for approval

por Husain, S R, Han, J, Au, P, Shannon, K, Puri, R K
Publicado 2015

In Vivo Overexpression of IL-13 Receptor α2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice

por Kawakami, Koji, Kawakami, Mariko, Snoy, Philip J., Husain, Syed R., Puri, Raj K.
Publicado 2001

Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy

por Sato, Yuki, Vatsan, Ramjay, Joshi, Bharat H, Husain, Syed R, Puri, Raj K
Publicado 2014

An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.

por Gokhale, P. C., Radhakrishnan, B., Husain, S. R., Abernethy, D. R., Sacher, R., Dritschilo, A., Rahman, A.
Publicado 1996

The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients

por Umar, F., Hatta, M., Husain, D.R., Natzir, R., Dwiyanti, R., Junita, A.R., Primaguna, M.R.
Publicado 2019

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy

por Knudson, Karin M., Hwang, SuJin, McCann, Mondona S., Joshi, Bharat H., Husain, Syed R., Puri, Raj K.
Publicado 2022

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling

por Hall, Bradford, Nakashima, Hideyuki, Sun, Zhi-Jun, Sato, Yuki, Bian, Yansong, Husain, Syed R, Puri, Raj K, Kulkarni, Ashok B
Publicado 2013

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort

por Mullen, Michael T., Messé, Steven R., Kasner, Scott E., Sansing, Lauren, Husain, M. R., Norman, Gary L., Shums, Zakera, Cucchiara, Brett L.
Publicado 2012

Molecular characterisation of mutations associated with resistance to first- and second-line drugs among Indonesian patients with tuberculosis

por Umar, Faiqah F., Husain, Dirayah R., Hatta, Mochammad M., Natzir, Rosdiana R., Sjahril, Rizalinda S., Dwiyanti, Ressy R., Junita, Ade R., Primaguna, Muhammad R.
Publicado 2020

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke

por Khazaal, Ossama, Rothstein, Aaron, Husain, Muhammad R., Broderick, Matthew, Cristancho, Daniel, Reyes-Esteves, Sahily, Khan, Farhan, Favilla, Christopher G., Messé, Steven R., Mullen, Michael T.
Publicado 2021

Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation

por Vatsan, Ramjay S, Bross, Peter F, Liu, Ke, Theoret, Marc, De Claro, Angelo R, Lu, Jinhua, Helms, Whitney, Niland, Brian, Husain, Syed R, Puri, Raj K
Publicado 2013